09.09.2014 Views

Autism Studies and Related Medical Conditions, January 2009 - TACA

Autism Studies and Related Medical Conditions, January 2009 - TACA

Autism Studies and Related Medical Conditions, January 2009 - TACA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

156. Chonmaitree T et al. Presence of cytomegalovirus <strong>and</strong> herpes simplex virus in<br />

middle ear fluids from children with acute otitis media. Clin Infect Dis 1992 15(4):650-3<br />

PMID 1330014<br />

157. The common mucosal immune system <strong>and</strong> current strategies for induction of<br />

immune responses in external secretions. J Clin Immunol. 1987 Jul;7(4):265-76. PMID:<br />

3301884<br />

158. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence<br />

for a common mucosal immune system in humans. Proc Natl Acad Sci U S A. 1987<br />

Apr;84(8):2449-53. PMID: 3470804<br />

159. Management of chronic otitis media with effusion: the role of glutathione.<br />

Laryngoscope. 2001 Aug;111(8):1486-9. PMID: 11568588<br />

"BACKGROUND: The inflammatory cells documented in chronic otitis media with<br />

effusion (OME) spontaneously release oxidants which can induce middle ear (ME)<br />

epithelial cell damage. Glutathione (GSH), a major extracellular antioxidant in humans,<br />

plays a central role in antioxidant defense. PURPOSE: To evaluate the effects of GSH<br />

treatment on chronic otitis media with effusion (OME). SUBJECTS AND INTERVENTION:<br />

Sixty children with chronic OME were enrolled, 30 of whom were r<strong>and</strong>omly assigned to<br />

the treatment group <strong>and</strong> 30 to the placebo group. Patients in the treatment group<br />

received 600 mg glutathione in 4 mL saline per day subdivided into five 2-minute<br />

administrations given by nasal aerosol every 3 or 4 waking hours for 2 weeks. Patients<br />

in the control group received 4 mL saline per day following the same procedure as for<br />

GSH treatment. RESULTS: Three months after therapy improvement had occurred in<br />

66.6% of patients in the GSH-treated group <strong>and</strong> in 8% of the control subjects (P

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!